Chronic Plantar Fasciopathy. Plantar fascial fibromatosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 25–40 years Clinical diagnosis of chronic plantar fasciopathy (symptom duration >3 months) by doctor of medicine Presence of localized tenderness at the medial calcaneal tuberosity Pain during the first steps after a period of rest Willingness to participate and provide written informed consent absence of specific spinal pathology or musculoskeletal disoredrs lower limbs No prior structured physiotherapy for the condition in the last 3 months Ability to participate in the full intervention period
Exclusion criteria
Exclusion criteria: History of corticosteroid injection in the affected foot within the previous 6 months Previous foot or ankle surgery Systemic inflammatory or rheumatologic diseases (e.g., rheumatoid arthritis, lupus) Neurological disorders affecting lower limb function (e.g., neuropathy, radiculopathy) Structural foot deformities (e.g., severe pes planus, pes cavus, or congenital deformities) Acute musculoskeletal injuries of the lower extremity during the study period Participation in other physical therapy or rehabilitation programs during the study Use of analgesic or anti-inflammatory medication that could affect pain outcomes without a stable dosage Failure to attend more than 20% of treatment sessions or poor adherence to protocol Pregnancy (for females)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity and functional capacity. Timepoint: First week and 8 weeks. Method of measurement: Visual Analog Scale (VAS) and Foot Functional Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Sports Sciences Research Institute